Xencor reported $-12042000 in Net Income for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US USD 2.47B 1.48B
Alnylam Pharmaceuticals ALNY:US USD -207493000 198.43M
Amgen AMGN:US USD 1.62B 527M
Arrowhead Research ARWR:US USD -41325000 44.19M
AstraZeneca AZN:LN USD 901M 739M
Biogen BIIB:US USD 550.4M 584.3M
Bristol Myers Squibb BMY:US USD 2.02B 416M
Cytokinetics CYTK:US USD -137380000 4.93M
GlaxoSmithKline GSK:LN GBP 1.5B 8.82B
Johnson & Johnson JNJ:US USD 3.52B 938M
Karyopharm Therapeutics KPTI:US USD -38506000 2.18M
Macrogenics MGNX:US USD 12.8M 37.61M
Merk MRK:US USD 3.02B 231M
Novartis NOVN:VX USD 1.47B 107M
Pfizer PFE:US USD 5B 3.61B
Regeneron Pharmaceuticals REGN:US USD 1.2B 118.6M
Roche Holding ROG:VX 3.89B 4.64B
Seattle Genetics SGEN:US USD -148171000 42.64M
Xencor XNCR:US USD -12042000 20.72M